MRC Molecular Haematology Unit
At the MRC Molecular Haematology Unit, we aim to understand how stem cells produce mature blood cells in a healthy context, and how this process is perturbed in common blood disorders.
MRC MHU includes 14 research teams with over 140 scientists who share a common goal, to improve the prognosis of patients with inherited and acquired blood diseases.
This is an exciting time for the field of haematology. The -omics revolution is enabling scientists to unravel the complex molecular processes governing biology at unprecedented speed. At the MRC MHU our teams are committed to applying such cutting-edge techniques to better understand the molecular basis of blood diseases, and to develop treatments to improve the lives of patients. - Professor KJ Patel
Latest publications
TiO2 Alternative Coatings for Ferric Pyrophosphate Premixes: Stability and Bioaccessibility Relative to Ferrous Fumarate
Journal article
Teichman DL. et al, (2026), Innovative Food Science and Emerging Technologies, 111
FINE-EM-seq: a rapid isothermal amplification method enabling comprehensive methylome profiling of zebrafish early embryos
Journal article
Ding C. et al, (2026), Cell Insight, 5
PD-1 signaling and PD-1 blockade-mediated tumor control are established at microvillar T cell contacts.
Journal article
Jenkins E. et al, (2026), Sci Immunol, 11
Low-dose IL-2 fails to expand Tregs after alemtuzumab: insight into impaired immune tolerance in multiple sclerosis.
Journal article
Georgieva ZG. et al, (2026), Brain
Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies.
Journal article
Chen LY. et al, (2026), Blood